Complete Filing Data
SANGAMO THERAPEUTICS, INC reported Operating Expenses of $160.79 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SANGAMO THERAPEUTICS, INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$122.9M | -$97.9M | -$257.8M | -$192.3M | -$178.3M | -$121.0M | -$95.2M | -$68.3M | -$54.6M | -$71.7M | -$40.7M | -$26.4M | -$26.6M | -$22.3M | -$35.8M | -$24.9M | -$18.6M |
| Revenue * | $39.6M | $57.8M | $176.2M | $111.3M | $110.7M | $118.2M | $102.4M | $84.5M | $36.6M | $19.4M | $39.5M | $45.9M | $24.1M | $21.7M | $10.3M | $20.8M | $22.2M |
| Operating Expenses | $160.8M | $161.8M | $450.2M | $312.6M | $294.0M | $247.7M | $207.6M | $161.6M | $92.9M | $91.9M | $86.4M | $72.7M | $50.8M | $43.9M | $46.1M | $45.7M | $41.6M |
| Research And Development Expense | $112.7M | $111.5M | $234.1M | $249.9M | $230.8M | $180.6M | $145.9M | $114.9M | $65.7M | $65.6M | $67.2M | $57.0M | $37.0M | $31.7M | $32.1M | $33.2M | $29.0M |
| Operating Income Loss | -$121.2M | -$104.0M | -$274.0M | -$201.3M | -$183.3M | -$129.6M | -$105.2M | -$77.2M | -$56.4M | -$72.6M | -$46.9M | -$26.8M | -$26.7M | -$22.2M | -$35.8M | -$24.9M | -$19.4M |
| General And Administrative Expense | $34.9M | $44.7M | $61.2M | $62.7M | $63.2M | $67.1M | $61.7M | $46.7M | $27.2M | $26.3M | $19.2M | $15.7M | $13.8M | $12.1M | $14.0M | $12.6M | $12.6M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | -$233.0K | $1.1M | -$597.0K | -$339.0K | -$284.0K | $592.0K | -$4.0K | -$306.0K | $20.0K | $25.0K | -$37.0K | -$14.0K | $14.0K | $18.0K | -$24.0K | -$258.0K |
| Comprehensive Income Net Of Tax | -$116.9M | -$100.9M | -$254.0M | -$196.7M | -$187.7M | -$113.1M | -$96.2M | -$69.5M | -$54.9M | -$71.6M | -$40.7M | -$26.5M | -$26.6M | -$22.3M | -$35.7M | -$24.9M | |
| Income Tax Expense Benefit | -$568.0K | -$167.0K | -$5.1M | $429.0K | $306.0K | $345.0K | $0.00 | $0.00 | $0.00 | -$14.0K | -$5.7M | ||||||
| Revenue From Grants | $607.0K | $508.0K | $1.7M | $2.0M | $2.5M | $3.5M | $4.2M | $4.0M | $634.0K | ||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$123.5M | -$98.1M | -$262.9M | -$191.8M | -$178.0M | -$120.8M | -$95.4M | -$68.9M | -$54.6M | -$71.7M | -$46.4M | -$26.4M | -$26.6M | ||||
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | -$11.0K | -$126.0K | -$233.0K | -$555.0K | $0.00 | ||||||||||
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $4.6M | $8.4M | -$8.3M | $1.6M | $1.1M | ||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $2.8M | -$4.6M | -$8.4M | $8.3M | -$1.6M | -$1.1M | $0.00 | ||||||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$254.0M | -$196.7M | -$187.7M | -$113.3M | -$96.4M | -$70.1M | -$54.9M | -$71.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$34.9M | -$20.0M | -$30.6M | $10.7M | -$36.1M | -$49.1M | -$104.2M | -$114.5M | $21.1M | -$53.2M | -$43.2M | -$44.0M | -$47.7M | -$47.2M | -$45.9M | -$40.6M | -$1.6M | -$35.9M | -$42.9M | $4.6M | -$27.3M | -$30.3M | -$42.2M | -$18.7M | -$12.8M | -$16.6M | -$20.2M | -$13.1M | -$12.4M | -$12.5M | -$16.6M | -$9.6M | -$19.0M | -$26.6M | -$16.5M | -$14.0M | -$9.2M | -$12.1M | -$5.3M | -$4.3M | -$7.5M | -$7.0M | -$7.6M | -$8.1M | -$6.1M | -$5.5M | -$6.9M | -$3.5M | -$5.8M | -$5.7M | -$7.3M | -$6.4M | -$9.6M | -$10.3M | -$9.6M | -$8.7M | -$3.9M |
| Revenue * | $581.0K | $18.3M | $6.4M | $49.4M | $356.0K | $481.0K | $9.4M | $6.8M | $158.0M | $26.5M | $29.4M | $28.2M | $28.6M | $27.9M | $26.3M | $25.8M | $57.8M | $21.6M | $13.1M | $54.9M | $22.0M | $17.5M | $8.1M | $26.8M | $23.6M | $21.4M | $12.6M | $13.1M | $11.8M | $8.3M | $3.4M | $8.9M | $2.8M | $3.7M | $3.9M | $9.1M | $8.6M | $8.4M | $13.5M | $15.0M | $12.4M | $10.4M | $8.1M | $6.9M | $5.7M | $6.9M | $4.6M | $8.9M | $4.9M | $4.6M | $3.2M | $4.7M | $1.9M | $1.5M | $2.2M | $2.9M | $6.5M |
| Operating Expenses | $36.1M | $36.2M | $36.1M | $38.8M | $37.4M | $52.0M | $115.8M | $130.4M | $139.9M | $81.4M | $75.1M | $73.5M | $77.0M | $76.6M | $72.6M | $69.2M | $61.5M | $59.5M | $57.6M | $53.4M | $51.2M | $51.1M | $52.0M | $47.6M | $39.8M | $40.6M | $33.6M | $26.8M | $24.8M | $21.0M | $20.2M | $18.8M | $22.0M | $30.5M | $20.6M | $24.8M | $21.3M | $20.6M | $19.7M | $19.4M | $20.1M | $17.4M | $15.7M | $15.0M | $11.9M | $12.4M | $11.5M | $12.3M | $10.7M | $10.3M | $10.5M | $11.1M | $11.4M | $11.8M | $11.8M | $11.7M | $10.4M |
| Research And Development Expense | $28.1M | $27.1M | $26.0M | $27.7M | $24.2M | $35.9M | $57.1M | $63.0M | $63.2M | $65.1M | $60.0M | $58.6M | $62.5M | $60.1M | $56.4M | $45.3M | $41.5M | $41.5M | $36.3M | $36.5M | $34.9M | $28.8M | $29.3M | $23.5M | $18.4M | $15.0M | $12.9M | $17.0M | $19.5M | $15.3M | $16.7M | $15.6M | $15.0M | $16.3M | $13.5M | $12.1M | $8.7M | $9.3M | $8.2M | $7.6M | $7.6M | $7.3M | $7.8M | $8.1M | $8.3M | $8.8M | $7.1M | ||||||||||
| Operating Income Loss | -$35.6M | -$17.9M | -$29.6M | $10.6M | -$37.1M | -$51.5M | -$106.4M | -$123.6M | $18.0M | -$54.9M | -$45.7M | -$45.3M | -$48.4M | -$48.7M | -$46.3M | -$3.7M | -$37.9M | -$44.5M | -$29.2M | -$33.5M | -$43.9M | -$16.2M | -$19.1M | -$21.0M | -$13.0M | -$12.8M | -$16.8M | -$19.2M | -$26.8M | -$16.7M | -$12.7M | -$12.3M | -$6.2M | -$7.7M | -$7.0M | -$7.6M | -$6.2M | -$5.5M | -$6.9M | -$5.8M | -$5.7M | -$7.3M | -$9.6M | -$10.3M | -$9.6M | -$8.7M | -$3.9M | ||||||||||
| General And Administrative Expense | $8.0M | $9.1M | $10.1M | $11.0M | $12.0M | $11.8M | $13.9M | $16.0M | $18.1M | $16.2M | $15.1M | $14.9M | $14.5M | $16.5M | $16.1M | $16.2M | $17.9M | $16.1M | $14.9M | $14.6M | $17.1M | $11.0M | $11.3M | $10.1M | $6.4M | $6.0M | $7.3M | $5.0M | $11.1M | $5.4M | $4.6M | $5.0M | $4.7M | $3.7M | $4.0M | $3.6M | $3.2M | $3.1M | $3.3M | $3.1M | $2.7M | $3.2M | $3.6M | $3.7M | $3.5M | $2.9M | $3.3M | ||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$233.0K | $494.0K | -$258.0K | $604.0K | $135.0K | -$153.0K | -$1.1M | -$45.0K | -$35.0K | $44.0K | -$633.0K | $392.0K | $254.0K | -$59.0K | $484.0K | $253.0K | -$87.0K | $230.0K | -$99.0K | $12.0K | -$51.0K | -$112.0K | -$14.0K | $8.0K | $83.0K | $57.0K | -$28.0K | $50.0K | $20.0K | $12.0K | $9.0K | $27.0K | -$26.0K | -$1.0K | $22.0K | -$4.0K | $15.0K | -$19.0K | $3.0K | $20.0K | ||||||||||||
| Comprehensive Income Net Of Tax | -$34.9M | -$15.9M | -$28.6M | $12.3M | -$36.2M | -$50.3M | -$104.8M | -$114.7M | $23.8M | -$59.0M | -$49.4M | -$46.9M | -$50.3M | -$45.9M | -$50.6M | $1.7M | -$33.8M | -$44.3M | -$31.4M | -$28.4M | -$43.4M | -$12.9M | -$16.4M | -$20.3M | -$12.3M | -$12.5M | -$16.7M | -$19.0M | -$26.6M | -$16.4M | -$9.2M | -$12.2M | -$5.3M | -$7.5M | -$7.0M | -$7.6M | -$6.1M | -$5.5M | -$6.9M | -$5.8M | -$5.7M | -$7.3M | -$9.6M | -$10.3M | -$9.6M | ||||||||||||
| Income Tax Expense Benefit | -$161.0K | $27.0K | $119.0K | $88.0K | $74.0K | $98.0K | $1.3M | -$6.3M | $194.0K | $30.0K | $82.0K | $58.0K | $86.0K | $24.0K | $262.0K | $237.0K | $0.00 | $0.00 | $0.00 | -$3.0K | -$24.0K | -$3.3M | -$748.0K | ||||||||||||||||||||||||||||||||||
| Revenue From Grants | $86.0K | $53.0K | $276.0K | $119.0K | $95.0K | $110.0K | $231.0K | $163.0K | $557.0K | $820.0K | $372.0K | $664.0K | $548.0K | $882.0K | $777.0K | $540.0K | $717.0K | $762.0K | $1.6M | $1.1M | $906.0K | $713.0K | $709.0K | $315.0K | |||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$35.1M | -$20.0M | -$30.5M | $10.8M | -$36.1M | -$49.0M | -$102.9M | -$120.8M | $21.3M | -$53.1M | -$43.1M | -$43.9M | -$12.4M | -$12.5M | -$19.0M | -$26.6M | -$16.5M | -$12.6M | -$12.1M | -$6.1M | -$7.5M | -$7.0M | -$7.6M | ||||||||||||||||||||||||||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | -$5.0K | -$6.0K | -$71.0K | $42.0K | -$36.0K | -$61.0K | -$54.0K | -$54.0K | -$72.0K | -$53.0K | -$555.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | -$1.9M | -$1.7M | $313.0K | $980.0K | $1.1M | -$80.0K | -$2.0M | $6.0M | $6.1M | $1.9M | $2.6M | -$1.3M | $4.7M | -$3.8M | -$1.8M | $1.6M | $4.1M | -$1.4M | $1.5M | $2.0K | |||||||||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $80.0K | $2.0M | -$6.0M | -$6.1M | -$1.9M | -$2.6M | $1.3M | -$4.7M | $3.8M | $1.8M | -$1.6M | -$4.1M | $1.4M | -$1.5M | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$59.0M | -$49.4M | -$46.9M | -$50.3M | -$45.9M | -$50.6M | $1.7M | -$33.8M | -$44.4M | -$31.5M | -$28.4M | -$43.5M | -$12.9M | -$16.4M | -$20.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$14.3M | $22.8M | $82.9M | $295.0M | $375.3M | $498.2M | $432.6M | $366.5M | $187.9M | $136.2M | $192.4M | $206.6M | $121.7M | $64.9M | $80.1M | $55.9M | $71.8M | $55.4M |
| Cash And Cash Equivalents At Carrying Value | $20.9M | $41.9M | $22.1M | $69.5M | $6.0M | $10.2M | $21.7M | $16.8M | $10.8M | $21.2M | $19.4M | |||||||
| Retained Earnings Accumulated Deficit | -$1.63B | -$1.50B | -$1.41B | -$1.15B | -$956.3M | -$778.0M | -$657.0M | -$562.7M | -$495.5M | -$440.9M | -$369.3M | -$328.6M | -$302.1M | -$275.5M | -$253.2M | -$217.5M | ||
| Property Plant And Equipment Net | $11.0M | $17.9M | $26.9M | $63.5M | $51.5M | $41.3M | $29.9M | $78.7M | $31.1M | $6.6M | $2.9M | $1.5M | $1.4M | $1.5M | $1.6M | $1.7M | ||
| Liabilities Current | $42.5M | $45.8M | $47.7M | $111.7M | $127.9M | $143.5M | $69.9M | $78.5M | $44.9M | $13.3M | $20.1M | $20.9M | $10.1M | $8.8M | $7.2M | $7.1M | ||
| Liabilities And Stockholders Equity | $59.7M | $101.6M | $165.3M | $562.5M | $721.9M | $938.6M | $637.5M | $590.4M | $286.7M | $157.9M | $217.2M | $243.2M | $140.8M | $82.5M | $87.3M | $63.0M | ||
| Common Stock Value | $3.5M | $2.1M | $1.8M | $1.7M | $1.5M | $1.4M | $1.2M | $1.0M | $856.0K | $709.0K | $703.0K | $690.0K | $622.0K | $531.0K | $526.0K | $454.0K | ||
| Assets Current | $35.8M | $51.7M | $94.3M | $300.3M | $398.8M | $659.7M | $405.5M | $410.5M | $248.4M | $149.6M | $212.6M | $190.9M | $97.3M | $68.4M | $85.7M | $61.3M | ||
| Assets | $59.7M | $101.6M | $165.3M | $562.5M | $721.9M | $938.6M | $637.5M | $590.4M | $286.7M | $157.9M | $217.2M | $243.2M | $140.8M | $82.5M | $87.3M | $63.0M | ||
| Accrued Employee Benefits Current | $17.7M | $14.6M | $8.9M | $21.5M | $20.8M | $20.7M | $13.6M | $9.5M | $5.5M | $2.9M | $2.7M | $2.9M | $3.2M | $2.5M | $1.7M | $1.4M | ||
| Accounts Receivable Net Current | $371.0K | $526.0K | $923.0K | $3.7M | $6.0M | $5.2M | $36.9M | $4.7M | $3.3M | $5.0M | $2.5M | $10.4M | $3.2M | $4.1M | $919.0K | $366.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.5M | -$7.5M | -$4.6M | -$8.4M | -$4.0M | $5.4M | -$2.4M | -$1.4M | -$286.0K | $20.0K | -$25.0K | $12.0K | $26.0K | $12.0K | -$6.0K | |||
| Liabilities | $74.0M | $78.9M | $82.4M | $267.6M | $346.6M | $441.2M | $204.8M | $223.1M | $98.8M | $21.7M | $24.8M | $36.6M | $19.1M | $17.6M | $7.2M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $20.9M | $43.4M | $46.7M | $101.9M | $180.4M | $132.8M | $81.9M | $143.9M | $53.3M | $22.1M | ||||||||
| Interest Receivable Current | $403.0K | $794.0K | $349.0K | $1.0M | $682.0K | $375.0K | $240.0K | $224.0K | $307.0K | $423.0K | $338.0K | $190.0K | $331.0K | $337.0K | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $273.0K | $2.3M | $1.2M | -$2.8M | $825.0K | $4.7M | $5.8M | $673.0K | -$221.0K | -$827.0K | -$1.1M | -$912.0K | -$889.0K | |||||
| Additional Paid In Capital Common Stock | $1.61B | $1.53B | $1.49B | $1.45B | $1.33B | $1.27B | $1.09B | $929.6M | $682.8M | $576.4M | $561.0M | $534.5M | $423.2M | |||||
| Goodwill | $0.00 | $37.6M | $39.7M | $42.8M | $39.3M | $40.0M | $1.6M | $1.6M | $1.6M | $1.6M | ||||||||
| Other Assets Noncurrent | $871.0K | $879.0K | $1.3M | $17.0M | $15.3M | $13.6M | $9.1M | $3.4M | $1.2M | $169.0K | $152.0K | $139.0K | $40.0K | |||||
| Accounts Payable And Accrued Liabilities Current | $21.5M | $11.0M | $6.3M | $8.2M | $8.7M | $4.4M | $4.0M | $5.5M | $5.7M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$22.5M | -$3.3M | -$55.2M | -$78.4M | $47.5M | $50.9M | -$62.0M | $90.6M | $31.3M | -$47.4M | ||||||||
| Prepaid Expense And Other Assets Current | $4.4M | $5.2M | $9.3M | $18.2M | $15.9M | $12.0M | $5.4M | $5.3M | $1.5M | $1.8M | ||||||||
| Cash And Cash Equivalents Period Increase Decrease | $27.8M | -$47.4M | $63.5M | -$4.2M | -$11.5M | $4.9M | $6.0M | -$10.4M | $1.8M | |||||||||
| Restricted Cash Noncurrent | $0.00 | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $3.5M | $3.5M | |||||||||
| Other Liabilities Noncurrent | $580.0K | $933.0K | $1.2M | $1.2M | $1.2M | $7.0M | $5.7M | $2.0M | ||||||||||
| Contract With Customer Liability Current | $899.0K | $7.6M | $0.00 | $51.8M | $85.7M | $91.6M | $38.7M | $47.6M | $28.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $6.2M | $19.6M | $4.9M | $39.1M | $23.7M | $56.7M | $134.9M | $233.6M | $335.6M | $309.2M | $318.3M | $334.5M | $375.3M | $406.0M | $445.5M | $470.4M | $521.4M | $511.5M | $394.3M | $419.1M | $445.1M | $328.5M | $379.9M | $387.9M | $182.4M | $186.7M | $194.0M | $125.7M | $143.8M | $160.0M | $179.4M | $203.6M | $199.9M | $207.5M | $210.1M | $214.4M | $217.4M | $126.1M | $59.4M | $61.6M | $66.4M | $70.2M | $74.3M | $84.2M | $91.6M | ||||||||||
| Cash And Cash Equivalents At Carrying Value | $29.6M | $38.3M | $25.2M | $39.2M | $27.8M | $54.4M | $45.2M | $56.5M | $66.8M | $78.2M | $100.4M | $94.6M | $117.7M | $120.3M | $178.9M | $177.0M | $169.9M | $123.0M | $131.3M | $259.4M | $467.4M | $85.7M | $80.4M | $114.3M | $169.2M | $81.0M | $140.4M | $39.3M | $59.4M | $30.7M | $49.8M | $29.9M | $69.8M | $18.5M | $28.0M | $13.0M | $33.0M | $34.3M | $10.8M | $25.3M | $11.2M | $99.3M | $126.8M | $80.3M | $12.1M | $12.2M | $13.7M | $18.5M | $24.5M | $21.7M | $8.4M | $6.9M | $9.1M | $12.8M | |
| Retained Earnings Accumulated Deficit | -$1.59B | -$1.55B | -$1.53B | -$1.48B | -$1.49B | -$1.46B | -$1.35B | -$1.24B | -$1.13B | -$1.10B | -$1.04B | -$1.00B | -$918.8M | -$871.1M | -$823.9M | -$737.4M | -$735.8M | -$699.9M | -$661.5M | -$634.2M | -$603.9M | -$544.0M | -$531.2M | -$514.5M | -$482.4M | -$470.0M | -$457.5M | -$431.3M | -$412.3M | -$385.7M | -$355.2M | -$346.0M | -$333.9M | -$324.2M | -$316.7M | -$309.7M | -$294.0M | -$287.8M | -$282.4M | -$272.0M | -$266.2M | -$260.5M | -$246.9M | -$237.3M | |||||||||||
| Property Plant And Equipment Net | $14.8M | $15.7M | $16.9M | $19.1M | $20.6M | $22.0M | $28.4M | $60.7M | $59.9M | $56.0M | $53.5M | $51.6M | $50.8M | $49.6M | $45.2M | $35.3M | $33.9M | $31.3M | $26.5M | $21.0M | $18.3M | $50.5M | $37.2M | $33.6M | $8.5M | $8.3M | $7.3M | $4.9M | $3.0M | $3.2M | $3.1M | $3.2M | $3.0M | $1.6M | $1.6M | $1.4M | $1.5M | $1.6M | $1.5M | $1.5M | $1.5M | $1.7M | $1.6M | $1.6M | |||||||||||
| Liabilities Current | $50.1M | $47.7M | $49.6M | $43.2M | $39.0M | $40.2M | $48.5M | $53.8M | $57.8M | $122.4M | $120.0M | $118.5M | $131.9M | $136.9M | $132.8M | $123.6M | $93.9M | $62.1M | $80.6M | $82.0M | $91.1M | $74.1M | $75.9M | $49.4M | $42.9M | $41.7M | $13.1M | $13.9M | $14.5M | $10.1M | $22.1M | $21.1M | $20.0M | $19.5M | $16.8M | $16.4M | $7.0M | $7.1M | $6.0M | $6.0M | $6.2M | $5.6M | $4.1M | $4.0M | |||||||||||
| Liabilities And Stockholders Equity | $88.6M | $97.6M | $86.2M | $111.3M | $93.0M | $129.0M | $219.7M | $325.1M | $440.6M | $593.9M | $617.1M | $654.3M | $772.4M | $835.4M | $877.1M | $963.7M | $894.7M | $584.3M | $640.2M | $673.5M | $542.7M | $606.6M | $627.7M | $281.2M | $269.8M | $283.0M | $146.8M | $165.0M | $180.9M | $197.0M | $232.5M | $229.9M | $238.5M | $247.3M | $250.8M | $255.5M | $140.4M | $74.2M | $75.8M | $81.8M | $86.3M | $90.4M | $88.3M | $95.6M | |||||||||||
| Common Stock Value | $3.2M | $2.7M | $2.3M | $2.1M | $2.1M | $2.0M | $1.8M | $1.8M | $1.7M | $1.6M | $1.5M | $1.5M | $1.5M | $1.5M | $1.4M | $1.4M | $1.4M | $1.2M | $1.2M | $1.2M | $1.0M | $1.0M | $1.0M | $870.0K | $841.0K | $835.0K | $718.0K | $706.0K | $706.0K | $704.0K | $700.0K | $698.0K | $695.0K | $683.0K | $681.0K | $678.0K | $614.0K | $540.0K | $535.0K | $529.0K | $527.0K | $526.0K | $525.0K | $524.0K | |||||||||||
| Assets Current | $44.1M | $49.9M | $37.6M | $58.1M | $40.1M | $68.6M | $147.6M | $159.6M | $227.1M | $336.6M | $343.1M | $340.1M | $447.4M | $554.1M | $606.9M | $700.3M | $679.4M | $370.9M | $384.2M | $461.8M | $362.6M | $468.2M | $550.0M | $236.3M | $242.3M | $255.7M | $133.8M | $148.8M | $176.2M | $191.1M | $227.7M | $221.0M | $203.9M | $173.2M | $203.0M | $220.2M | $126.1M | $53.7M | $61.5M | $62.4M | $63.7M | $81.8M | $86.7M | $94.0M | |||||||||||
| Assets | $88.6M | $97.6M | $86.2M | $111.3M | $93.0M | $129.0M | $219.7M | $325.1M | $440.6M | $593.9M | $617.1M | $654.3M | $772.4M | $835.4M | $877.1M | $963.7M | $894.7M | $584.3M | $640.2M | $673.5M | $542.7M | $606.6M | $627.7M | $281.2M | $269.8M | $283.0M | $146.8M | $165.0M | $180.9M | $197.0M | $232.5M | $229.9M | $238.5M | $247.3M | $250.8M | $255.5M | $140.4M | $74.2M | $75.8M | $81.8M | $86.3M | $90.4M | $88.3M | $95.6M | |||||||||||
| Accrued Employee Benefits Current | $17.1M | $15.4M | $14.0M | $11.0M | $5.7M | $6.3M | $17.3M | $13.1M | $12.9M | $19.0M | $13.9M | $12.5M | $18.6M | $17.4M | $13.1M | $17.9M | $13.3M | $8.6M | $11.0M | $8.7M | $6.2M | $6.6M | $4.3M | $3.2M | $4.5M | $2.9M | $2.0M | $2.8M | $2.2M | $1.7M | $2.8M | $2.0M | $1.7M | $2.7M | $2.0M | $1.5M | $2.0M | $1.4M | $1.1M | $1.8M | $1.3M | $996.0K | $1.4M | $1.0M | |||||||||||
| Accounts Receivable Net Current | $523.0K | $372.0K | $366.0K | $10.5M | $581.0K | $691.0K | $1.1M | $2.7M | $7.0M | $4.5M | $6.0M | $6.9M | $8.0M | $6.9M | $6.7M | $39.5M | $5.6M | $7.0M | $22.0M | $12.1M | $7.3M | $5.6M | $5.0M | $3.6M | $3.4M | $3.5M | $2.4M | $1.5M | $2.3M | $2.6M | $7.0M | $5.2M | $6.6M | $8.5M | $7.0M | $5.4M | $4.9M | $4.9M | $3.7M | $3.5M | $3.2M | $1.5M | $1.2M | $1.4M | |||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.4M | -$1.5M | -$5.5M | -$4.2M | -$5.9M | -$5.8M | -$6.6M | -$5.9M | -$5.8M | -$19.0M | -$13.2M | -$7.0M | -$623.0K | $2.0M | $714.0K | $1.6M | -$1.7M | -$3.8M | -$4.9M | -$765.0K | -$2.7M | -$244.0K | -$157.0K | -$385.0K | -$131.0K | -$143.0K | -$92.0K | $77.0K | $91.0K | $83.0K | $54.0K | -$3.0K | $25.0K | $53.0K | $33.0K | $21.0K | $26.0K | -$1.0K | $25.0K | $15.0K | -$7.0K | -$3.0K | -$2.0K | $17.0K | |||||||||||
| Liabilities | $82.4M | $78.0M | $81.3M | $72.1M | $69.3M | $72.3M | $84.8M | $91.4M | $105.0M | $284.8M | $298.8M | $319.8M | $366.4M | $389.9M | $407.7M | $442.8M | $383.5M | $189.9M | $220.9M | $227.7M | $213.5M | $226.7M | $239.9M | $98.8M | $83.1M | $89.0M | $21.1M | $21.1M | $20.9M | $17.6M | $29.0M | $30.0M | $31.0M | $37.2M | $36.5M | $38.1M | $14.2M | $14.8M | $14.3M | $15.4M | $16.1M | $16.1M | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $30.5M | $39.8M | $26.7M | $40.7M | $27.8M | $55.3M | $58.0M | $68.3M | $79.7M | $96.1M | $119.2M | $121.8M | $178.5M | $171.4M | $124.5M | $260.9M | $468.9M | $87.2M | $117.8M | $172.7M | $84.5M | $119.2M | $62.9M | $34.2M | $18.5M | ||||||||||||||||||||||||||||||
| Interest Receivable Current | $602.0K | $1.2M | $1.0M | $524.0K | $289.0K | $356.0K | $620.0K | $807.0K | $974.0K | $822.0K | $534.0K | $926.0K | $680.0K | $766.0K | $594.0K | $683.0K | $562.0K | $373.0K | $483.0K | $256.0K | $398.0K | $310.0K | $299.0K | $402.0K | $399.0K | $393.0K | $398.0K | $313.0K | $311.0K | $383.0K | $208.0K | $273.0K | $258.0K | $311.0K | $199.0K | $370.0K | $542.0K | $509.0K | |||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $273.0K | $1.0M | -$164.0K | -$824.0K | $744.0K | $1.2M | $459.0K | -$60.0K | -$72.0K | -$241.0K | -$295.0K | |||||||||||||||||||||||||||||||||||||||||||
| Additional Paid In Capital Common Stock | $1.59B | $1.57B | $1.54B | $1.52B | $1.52B | $1.52B | $1.49B | $1.48B | $1.47B | $1.42B | $1.37B | $1.34B | $1.32B | $1.31B | $1.29B | $1.26B | $1.25B | $1.10B | $1.08B | $1.08B | $934.1M | $923.2M | $918.2M | $696.4M | $668.3M | $663.4M | $582.6M | $574.3M | $571.5M | $564.4M | $558.0M | $545.2M | $540.6M | $533.6M | |||||||||||||||||||||
| Goodwill | $0.00 | $0.00 | $0.00 | $34.5M | $36.7M | $38.9M | $40.5M | $41.5M | $41.0M | $41.0M | $39.3M | $38.6M | $38.3M | $39.8M | $39.3M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | ||||||||||||||||||||||||
| Other Assets Noncurrent | $871.0K | $890.0K | $882.0K | $15.0M | $17.4M | $16.2M | $17.2M | $16.1M | $16.1M | $15.4M | $14.9M | $14.1M | $12.7M | $13.8M | $9.5M | $7.7M | $7.6M | $4.1M | $6.4M | $1.0M | $1.0M | $1.2M | $159.0K | $146.0K | $146.0K | $185.0K | $193.0K | $157.0K | $108.0K | ||||||||||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $17.9M | $19.2M | $16.9M | $17.6M | $22.0M | $22.5M | $30.1M | $16.4M | $14.4M | $11.0M | $10.1M | $9.2M | $7.4M | $6.3M | $7.0M | $3.1M | $8.9M | $9.5M | $6.8M | $8.0M | $5.7M | $6.1M | $2.7M | $3.3M | $2.5M | $1.7M | $2.6M | $2.4M | $2.5M | $2.6M | |||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$16.7M | $8.6M | -$22.2M | -$58.6M | -$8.4M | $5.3M | -$59.5M | -$19.1M | |||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid Expense And Other Assets Current | $8.4M | $6.6M | $7.8M | $8.4M | $11.7M | $12.6M | $13.7M | $12.6M | $13.7M | $18.0M | $21.1M | $15.0M | $15.4M | $16.7M | $12.1M | $11.2M | $8.4M | $4.9M | $4.7M | $5.8M | $3.7M | $3.4M | $5.1M | $2.8M | |||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$3.6M | -$36.5M | $19.2M | $116.6M | -$9.5M | $7.7M | -$3.9M | ||||||||||||||||||||||||||||||||||||||||||||||||
| Restricted Cash Noncurrent | $0.00 | $1.5M | $1.5M | $1.5M | $0.00 | $0.00 | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $3.5M | $79.9M | |||||||||||||||||||||||||||||||||
| Other Liabilities Noncurrent | $977.0K | $962.0K | $933.0K | $1.2M | $1.2M | $1.2M | $1.3M | $1.3M | $1.2M | $1.3M | $1.3M | $1.2M | $7.6M | $7.4M | $7.2M | $6.2M | $6.1M | $5.9M | $5.5M | $3.3M | $1.9M | $1.7M | |||||||||||||||||||||||||||||||||
| Contract With Customer Liability Current | $7.6M | $7.6M | $7.6M | $774.0K | $1.5M | $6.9M | $9.6M | $71.9M | $78.8M | $80.8M | $90.5M | $94.0M | $94.4M | $87.8M | $61.4M | $36.6M | $47.6M | $50.8M | $54.8M | $51.1M | $57.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $70.7M | $28.4M | $14.6M | $84.7M | $32.9M | $153.1M | $142.0M | $231.7M | $97.5M | $337.0K | $19.7M | $102.2M | $76.1M | $1.7M | $51.9M | $1.2M | $26.8M |
| Investing Cash Flow * | -$102.0K | $37.5M | $153.5M | $59.3M | $248.2M | -$271.6M | -$59.8M | -$178.1M | -$77.4M | $18.1M | $77.5M | -$100.7M | -$68.1M | $11.3M | -$20.0M | $12.4M | -$19.2M |
| Operating Cash Flow * | -$97.2M | -$67.1M | -$224.8M | -$223.6M | -$233.3M | $169.9M | -$144.4M | $36.6M | $11.2M | -$65.9M | -$33.7M | -$5.7M | -$19.5M | -$8.1M | -$25.9M | -$23.9M | -$6.1M |
| Share Based Compensation | $9.1M | $12.4M | $27.4M | $31.7M | $33.0M | $25.7M | $19.3M | $14.7M | $9.1M | $15.1M | $11.7M | $9.2M | $6.1M | $5.3M | $8.1M | $7.8M | $8.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$830.0K | -$4.4M | -$10.3M | $4.9M | $7.2M | $10.4M | $6.7M | $2.8M | $669.0K | $1.1M | -$376.0K | $258.0K | $480.0K | -$14.0K | $13.0K | -$97.0K | $96.0K |
| Increase Decrease In Accounts Receivable | -$155.0K | -$397.0K | -$2.8M | -$2.3M | $789.0K | -$31.7M | $32.2M | $1.3M | -$1.6M | $2.1M | -$7.8M | $7.2M | -$1.0M | $3.4M | $553.0K | $297.0K | -$431.0K |
| Depreciation Depletion And Amortization | $4.0M | $5.1M | $15.1M | $12.1M | $9.4M | $5.7M | $3.9M | $2.4M | $1.5M | $997.0K | $988.0K | $549.0K | $569.0K | $660.0K | $646.0K | $676.0K | $572.0K |
| Increase Decrease In Employee Related Liabilities | $3.1M | $5.7M | -$12.7M | $941.0K | $373.0K | $6.9M | $4.1M | $2.6M | $2.6M | $137.0K | -$105.0K | -$341.0K | $721.0K | $800.0K | $315.0K | -$28.0K | $997.0K |
| Payments To Acquire Property Plant And Equipment | $102.0K | $267.0K | $21.2M | $20.2M | $23.3M | $14.7M | $20.7M | $43.1M | $3.8M | $732.0K | $2.4M | $621.0K | $432.0K | $723.0K | $576.0K | $695.0K | $272.0K |
| Increase Decrease In Accrued Interest Receivable Net | -$392.0K | $445.0K | -$686.0K | $353.0K | $307.0K | $135.0K | $16.0K | -$83.0K | -$116.0K | $85.0K | $148.0K | -$141.0K | -$6.0K | -$4.0K | $147.0K | ||
| Stock Issued During Period Value Share Based Compensation | -$3.3M | -$904.0K | -$1.5M | -$2.0M | $2.4M | $8.6M | $3.7M | $14.5M | $15.1M | -$481.0K | $4.3M | $7.5M | $6.1M | $1.2M | $1.2M | $738.0K | $488.0K |
| Proceeds From Issuance Of Common Stock | $21.5M | $21.9M | $15.1M | $2.0M | $2.0M | $1.5M | $818.0K | $1.1M | $6.8M | $12.9M | $8.6M | $1.7M | $1.8M | $1.2M | $21.8M | ||
| Payments To Acquire Marketable Securities | $0.00 | $59.6M | $277.4M | $338.2M | $570.8M | $443.7M | $451.2M | $252.3M | $218.6M | $258.0M | $227.8M | $118.9M | $91.4M | $113.0M | $100.0M | $79.4M | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.8M | -$14.2M | $5.6M | $13.3M | -$7.7M | $10.7M | -$4.2M | -$6.4M | $3.2M | -$2.3M | -$764.0K | $4.3M | $544.0K | -$1.5M | |||
| Payments Related To Tax Withholding For Share Based Compensation | $3.3M | $904.0K | $1.5M | $2.1M | $3.3M | $765.0K | $422.0K | $254.0K | $654.0K | $776.0K | $1.5M | $4.6M | $2.0M | $48.0K | |||
| Proceeds From Sale And Maturity Of Marketable Securities | $354.6M | $602.9M | $314.6M | $404.8M | $391.8M | $178.7M | $237.5M | $337.9M | $127.8M | $51.1M | $103.5M | ||||||
| Increase Decrease In Contract With Customer Liability | -$6.7M | $13.4M | -$161.2M | -$91.3M | -$84.2M | $216.5M | -$35.7M | $99.4M | $49.0M | -$5.2M | |||||||
| Increase Decrease In Deferred Revenue | $49.0M | -$5.2M | -$8.4M | $13.2M | -$2.2M | $11.1M | -$64.0K | -$11.7M | $3.6M | ||||||||
| Increase Decrease In Other Noncurrent Liabilities | -$352.0K | -$255.0K | -$20.0K | -$9.0K | $1.2M | $1.3M | $3.7M | $2.0M | $0.00 | ||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.1M | -$2.0M | $1.5M | $1.3M | -$263.0K | -$447.0K | $184.0K | $439.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $8.1M | $22.1M | $8.0M | -$1.6M | $15.2M | $409.0K | $216.0K | $10.6M | $3.4M | $185.0K | $3.2M | $101.4M | $2.2M | $108.0K | $847.0K | ||||||||||||||||
| Investing Cash Flow * | $0.00 | $35.8M | $35.7M | $1.7M | $45.3M | $23.7M | -$14.8M | -$11.6M | $6.1M | -$16.3M | $18.4M | $3.9M | -$3.7M | $4.7M | $7.2M | ||||||||||||||||
| Operating Cash Flow * | -$26.1M | -$48.7M | -$66.3M | -$59.0M | -$68.6M | -$18.9M | -$45.1M | -$18.1M | -$13.1M | -$20.4M | -$2.4M | $11.4M | -$8.0M | $2.9M | -$12.0M | ||||||||||||||||
| Share Based Compensation | $2.6M | $2.7M | $8.3M | $7.7M | $7.5M | $5.6M | $4.5M | $3.1M | $2.8M | $3.2M | $3.0M | $1.9M | $1.3M | $1.4M | $2.0M | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.6M | -$962.0K | -$6.2M | $241.0K | $1.7M | $100.0K | -$1.2M | $1.3M | -$70.0K | -$172.0K | -$101.0K | $71.0K | -$61.0K | -$60.0K | -$48.0K | ||||||||||||||||
| Increase Decrease In Accounts Receivable | -$160.0K | -$232.0K | $3.3M | $925.0K | $1.5M | -$29.9M | $2.6M | $232.0K | -$2.6M | $46.0K | -$3.7M | $2.2M | -$546.0K | $589.0K | $1.1M | ||||||||||||||||
| Depreciation Depletion And Amortization | $1.0M | $1.4M | $3.5M | $2.8M | $1.9M | $1.3M | $715.0K | $588.0K | $301.0K | $245.0K | $147.0K | $123.0K | $147.0K | $168.0K | $162.0K | ||||||||||||||||
| Increase Decrease In Employee Related Liabilities | -$591.0K | -$2.6M | -$8.6M | -$8.3M | -$7.6M | -$5.0M | -$3.3M | -$2.3M | -$846.0K | -$1.0M | -$1.2M | -$1.7M | -$1.3M | -$676.0K | -$491.0K | ||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $10.2M | $2.8M | $8.0M | $3.8M | $6.0M | $2.6M | $468.0K | $252.0K | $1.1M | $126.0K | $68.0K | $218.0K | $110.0K | |||||||||||||||||
| Increase Decrease In Accrued Interest Receivable Net | -$354.0K | $229.0K | $7.0K | -$61.0K | $244.0K | $219.0K | $133.0K | $174.0K | $95.0K | -$25.0K | $45.0K | $68.0K | $39.0K | $55.0K | |||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | -$267.0K | -$420.0K | -$2.2M | -$203.0K | -$79.0K | -$402.0K | -$101.0K | -$194.0K | -$1.1M | -$101.0K | -$170.0K | -$1.6M | $617.0K | $1.4M | -$416.0K | $1.6M | $443.0K | $409.0K | $704.0K | $2.4M | $216.0K | $1.2M | $2.0M | $10.6M | |||||||
| Proceeds From Issuance Of Common Stock | $10.4M | $0.00 | $15.7M | $0.00 | $136.3M | $481.0K | $10.6M | $23.0K | $187.0K | $3.2M | $7.6M | $2.2M | $108.0K | $847.0K | |||||||||||||||||
| Payments To Acquire Marketable Securities | $0.00 | $36.2M | $65.8M | $97.9M | $43.6M | $87.1M | $63.4M | $39.0M | $84.8M | $39.4M | $16.8M | $16.6M | |||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $4.2M | -$4.9M | -$1.9M | $3.6M | -$3.8M | $345.0K | $10.2M | -$77.0K | -$418.0K | -$5.2M | -$2.5M | $1.7M | |||||||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $2.2M | $402.0K | $1.1M | $1.6M | $2.2M | $411.0K | $265.0K | $14.0K | $4.0K | $2.0K | $7.0K | ||||||||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $71.1M | $78.3M | $54.5M | $45.5M | $68.8M | $59.0M | $20.8M | ||||||||||||||||||||||||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$149.8M | -$21.0M | -$20.0M | -$8.3M | -$370.0K | $2.7M | ||||||||||||||||||||||||
| Increase Decrease In Deferred Revenue | $2.7M | -$870.0K | -$1.2M | $34.0K | $18.9M | -$560.0K | $12.6M | -$77.0K | |||||||||||||||||||||||
| Increase Decrease In Other Noncurrent Liabilities | $0.00 | $18.0K | $22.0K | $19.0K | $800.0K | $169.0K | -$50.0K | ||||||||||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.3M | -$670.0K | $367.0K | $222.0K | -$328.0K | $82.0K | $252.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.44 | -$0.49 | -$1.48 | -$1.25 | -$1.23 | -$0.90 | -$0.85 | -$0.70 | -$0.70 | -$1.02 | -$0.58 | -$0.39 | -$0.48 | -$0.42 | -$0.71 | -$0.55 | -$0.44 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 134.4M | 112.1M | 96.9M | 78.1M | 70.6M | 69.8M | 67.0M | 56.0M | 52.7M | 50.5M | 45.2M | 42.0M | |||||
| Common Stock Shares Authorized | 960.0M | 960.0M | 960.0M | 640.0M | 320.0M | 320.0M | 320.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 80.0M | 80.0M | 80.0M | 80.0M | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Common Stock Shares Outstanding | 350.7M | 212.8M | 178.1M | 166.8M | 145.9M | 142.1M | 116.0M | 102.2M | 85.6M | 70.9M | 70.4M | 69.1M | 62.2M | 53.1M | 52.6M | 45.4M | |
| Common Stock Shares Issued | 350.7M | 212.8M | 178.1M | 166.8M | 145.9M | 142.1M | 116.0M | 102.2M | 85.6M | 70.9M | 70.4M | 69.1M | 62.2M | 53.1M | 52.6M | 45.4M | |
| Weighted Average Number Of Shares Outstanding Basic | 280.2M | 201.7M | 174.4M | 154.3M | 144.6M | 134.4M | 112.1M | ||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 280.2M | 201.7M | 174.4M | 154.3M | 144.6M | 134.4M | 112.1M | ||||||||||
| Earnings Per Share Basic | $-0.44 | $-0.49 | $-1.48 | $-1.25 | $-1.23 | $-0.90 | $-0.85 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.11 | -$0.08 | -$0.14 | $0.04 | -$0.18 | -$0.27 | -$0.59 | -$0.66 | $0.12 | -$0.34 | -$0.29 | -$0.30 | -$0.33 | -$0.33 | -$0.32 | -$0.29 | -$0.01 | -$0.26 | -$0.37 | $0.04 | -$0.24 | -$0.26 | -$0.41 | -$0.18 | -$0.13 | -$0.17 | -$0.23 | -$0.15 | -$0.15 | -$0.17 | -$0.23 | -$0.14 | -$0.27 | -$0.38 | -$0.23 | -$0.20 | -$0.13 | -$0.17 | -$0.08 | -$0.06 | -$0.11 | -$0.10 | -$0.12 | -$0.13 | -$0.11 | -$0.10 | -$0.13 | -$0.07 | -$0.11 | -$0.11 | -$0.13 | -$0.12 | -$0.18 | -$0.20 | -$0.21 | -$0.19 | -$0.09 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 143.1M | 141.1M | 139.0M | 116.1M | 115.7M | 114.4M | 102.3M | 101.7M | 97.3M | 86.3M | 83.8M | 72.5M | 71.0M | 70.6M | 70.5M | 70.4M | 69.9M | 69.7M | 69.3M | 68.2M | 68.0M | 63.2M | 54.8M | 53.8M | 53.4M | 52.8M | 52.7M | 52.6M | 52.5M | 51.5M | 45.5M | 45.2M | 45.2M | ||||||||||||||||||||||||
| Common Stock Shares Authorized | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | 80.0M | ||||||||||||||||||||||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||||||||||||||||||||||||||||||||
| Common Stock Shares Outstanding | 101.8M | 101.6M | 87.0M | 84.1M | 83.5M | 71.8M | 70.6M | 70.6M | 70.4M | 70.0M | 69.8M | 69.5M | 68.3M | 68.1M | 67.8M | 61.4M | 54.0M | 53.5M | 52.9M | 52.6M | 52.6M | 52.5M | 52.4M | ||||||||||||||||||||||||||||||||||
| Common Stock Shares Issued | 101.8M | 101.6M | 87.0M | 84.1M | 83.5M | 71.8M | 70.6M | 70.6M | 70.4M | 70.0M | 69.8M | 69.5M | 68.3M | 68.1M | 67.8M | 61.4M | 54.0M | 53.5M | 52.9M | 52.7M | 52.6M | 52.5M | 52.4M | ||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 304.3M | 257.0M | 220.3M | 208.3M | 203.9M | 180.3M | 177.2M | 174.3M | 168.5M | 158.0M | 148.2M | 146.2M | 145.4M | 144.0M | 143.1M | 141.1M | 139.0M | ||||||||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 304.3M | 257.0M | 220.3M | 214.3M | 203.9M | 180.3M | 177.2M | 174.3M | 169.2M | 158.0M | 148.2M | 146.2M | 145.4M | 144.0M | 143.1M | 141.1M | 139.0M | ||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.11 | $-0.08 | $-0.14 | $0.05 | $-0.18 | $-0.27 | $-0.59 | $-0.66 | $0.13 | $-0.34 | $-0.29 | $-0.30 | $-0.33 | $-0.33 | $-0.32 | $-0.01 | $-0.26 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest And Other Income | $5.9M | $11.1M | $9.4M | $5.3M | $8.8M | $9.8M | $8.3M | $1.8M | $887.0K | $431.0K | |||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $9.1M | $12.4M | $27.4M | $31.7M | $33.0M | $25.7M | $19.3M | $14.7M | $9.1M | $15.1M | $11.7M | $9.2M | $6.1M | $5.3M | $8.1M | $7.8M | $8.5M |
| Collaboration Agreements | $36.0M | $18.9M | $37.8M | $43.9M | $21.7M | $18.2M | $6.1M | $16.8M | $21.6M | ||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $344.0K | $290.0K | $935.0K | $1.8M | $3.4M | $2.0M | $2.0M | $1.5M | $818.0K | $818.0K | $911.0K | $848.0K | $496.0K | $457.0K | $463.0K | $447.0K | $499.0K |
| Stock Issued During Period Value New Issues | $15.1M | $84.9M | $27.1M | $142.5M | $136.3M | $215.8M | $81.6M | $93.8M | $69.5M | $50.2M | |||||||
| Capital Expenditures Incurred But Not Yet Paid | $74.0K | $236.0K | $447.0K | $6.5M | $1.5M | $4.6M | $2.1M | $3.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest And Other Income | $355.0K | $386.0K | $309.0K | $350.0K | $416.0K | $451.0K | $3.5M | $2.8M | $3.3M | $1.8M | $2.6M | $1.3M | $834.0K | $1.6M | $625.0K | $2.4M | $1.9M | $1.5M | $1.9M | $3.1M | $1.7M | $3.4M | $2.5M | $810.0K | $681.0K | $277.0K | $160.0K | $238.0K | $243.0K | $187.0K | $101.0K | $151.0K | $154.0K | $109.0K | $66.0K | $39.0K | $14.0K | ||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.1M | $2.2M | $2.6M | $3.3M | $3.1M | $2.7M | $6.2M | $6.8M | $8.3M | $7.8M | $7.9M | $7.7M | $7.9M | $9.5M | $7.5M | $6.7M | $6.8M | $5.6M | $4.7M | $4.9M | $4.5M | $3.8M | $3.5M | $3.1M | |||||||||||||||||||||||
| Collaboration Agreements | $12.6M | $11.8M | $8.0M | $3.3M | $2.7M | $3.6M | $3.7M | $8.4M | $7.8M | $12.7M | $12.0M | $9.7M | $7.6M | $4.8M | $6.2M | $4.1M | $4.2M | $3.8M | $1.7M | $781.0K | $608.0K | $1.5M | $2.2M | $6.2M | |||||||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $179.0K | $146.0K | $719.0K | $1.1M | $2.1M | $1.2M | $1.1M | $690.0K | |||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $10.4M | $21.8M | $5.4M | $9.7M | $42.2M | $24.3M | $2.4M | $9.1M | $15.7M | $142.5M | -$321.0K | $136.6M | $215.8M | ||||||||||||||||||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $234.0K | $460.0K | $5.2M | $2.3M | $3.0M | $1.1M | $1.8M | $536.0K | $253.0K | $579.0K |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.